Sharon O'BRien
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sharon O'BRien has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Meredith Louise Borland
Emergency Department, Perth Children’s Hospital, Nedlands, Western Australia, Australia
6 shared publications - Franz E. Babl
Departments of Paediatrics and Critical Care The University of Melbourne Parkville Victoria Australia
5 shared publications - Simon Craig
Emergency Department, Monash Children's Hospital, Clayton, Victoria, Australia
4 shared publications - Stuart R. Dalziel
Children’s Emergency Department, Starship Children’s Hospital, Auckland, New Zealand
4 shared publications - Catherine L. Wilson
Clinical Sciences Murdoch Children's Research Institute Parkville Victoria Australia
3 shared publications - Ed Oakley
Department of Paediatrics University of Melbourne Parkville Victoria Australia
3 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Wiley in Emergency Medicine Australasia
- Vol. 38 (5)
Criteria for Safe Hospital Discharge in Bronchiolitis: A Systematic Review
Bronchiolitis is the leading cause of hospital presentation and admission for infants in Australasia. We aimed to synthesise current evidence on the effect of discharge criteria for infants (aged < 12 months) who are presenting to or are admitted to hospital with bronchiolitis, to inform a binational guideline recommendation update. Systematic searches were conducted on MEDLINE, EMBASE, PubMed, Cochrane Library and CINAHL (last search 19 February 2025) for non‐randomised studies evaluating hospital discharge criteria in bronchiolitis. The primary outcomes were length of stay (LOS) and readmission rates. The risk of bias (ROBINS‐I) and certainty of the evidence (GRADE) were appraised, and findings were narratively synthesised. GRADE evidence‐to‐decision methodology, expert consensus voting and interest‐holder consultation were used to finalise the recommendation update. Two retrospective observational studies were included ( N = 2697) (low to very low quality), reporting on unique discharge criteria. In both studies, use of the discharge criteria was associated with a significant reduction in LOS relative to alternative protocols. There was no significant difference in readmission rates observed in either study. There was low to very low certainty evidence across outcomes due to risk of bias, indirectness and imprecision. The review findings informed a recommendation update for safe discharge criteria in the 2025 Australasian Bronchiolitis Guideline update. Updated, prescriptive discharge criteria and flow chart were developed, covering clinical stability, oxygen saturation/support, feeding difficulties, caregiver confidence and education on deterioration, social factors and follow‐up. The revised criteria provide clinicians with increased certainty in decision‐making in bronchiolitis, albeit with further research needed.
- 3 September 2026
- Published by Wiley in Emergency Medicine Australasia
- Vol. 38 (5)
Open AccessCriteria for Safe Hospital Discharge in Bronchiolitis: A Systematic Review
Bronchiolitis is the leading cause of hospital presentation and admission for infants in Australasia. We aimed to synthesise current evidence on the effect of discharge criteria for infants (aged < 12 months) who are presenting to or are admitted to hospital with bronchiolitis, to inform a binational guideline recommendation update. Systematic searches were conducted on MEDLINE, EMBASE, PubMed, Cochrane Library and CINAHL (last search 19 February 2025) for non‐randomised studies evaluating hospital discharge criteria in bronchiolitis. The primary outcomes were length of stay (LOS) and readmission rates. The risk of bias (ROBINS‐I) and certainty of the evidence (GRADE) were appraised, and findings were narratively synthesised. GRADE evidence‐to‐decision methodology, expert consensus voting and interest‐holder consultation were used to finalise the recommendation update. Two retrospective observational studies were included ( N = 2697) (low to very low quality), reporting on unique discharge criteria. In both studies, use of the discharge criteria was associated with a significant reduction in LOS relative to alternative protocols. There was no significant difference in readmission rates observed in either study. There was low to very low certainty evidence across outcomes due to risk of bias, indirectness and imprecision. The review findings informed a recommendation update for safe discharge criteria in the 2025 Australasian Bronchiolitis Guideline update. Updated, prescriptive discharge criteria and flow chart were developed, covering clinical stability, oxygen saturation/support, feeding difficulties, caregiver confidence and education on deterioration, social factors and follow‐up. The revised criteria provide clinicians with increased certainty in decision‐making in bronchiolitis, albeit with further research needed.
- Open Access
- 20 July 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (8) , 1197-1215
Australasian Bronchiolitis Guideline: 2025 Update
Aim: To provide updated evidence‐based clinical guidance in the management of infants with bronchiolitis presenting to emergency departments (EDs), general paediatric, or intensive care units (ICUs) in Australia and Aotearoa New Zealand (AoNZ) following the first publication in 2016.Method: The Paediatric Research in Emergency Departments International Collaborative (PREDICT) network guideline working group appraised, summarised, and updated evidence from 1 January 2000 to 24 January 2024 addressing 41 questions (30 from the 2016 guideline and 11 new questions for 2025). Recommendations were developed using GRADE methodology and revised after a period of external consultation.Results: The literature search identified 26 467 citations with 431 included in 41 recommendations providing 11 new and 7 key updates. The key changes included: (i) refinement of the clinical features of bronchiolitis, (ii) addition of new risk factors for severity of illness, (iii) advice on the role of biomarkers for unexpected deterioration or admission to ICU, (iv) guidance on glucocorticoids in SARS‐CoV‐2 co‐infection, (v) guidance on combined glucocorticoids/inhaled epinephrine in severe bronchiolitis requiring ICU level care, (vi) refinement of oxygen saturation targets, (vii) guidance on humidified high flow therapy and continuous positive airway pressure, (viii) recommendation on use of RSV prevention therapies/immunisations for babies and mothers.Conclusion: The updated Australasian Bronchiolitis Guideline provides clinicians across Australasian settings with the latest evidence‐based guidance on the management of the commonest condition in infancy requiring hospital admission.
- 20 July 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (8) , 1197-1215
Open AccessAustralasian Bronchiolitis Guideline: 2025 Update
Aim: To provide updated evidence‐based clinical guidance in the management of infants with bronchiolitis presenting to emergency departments (EDs), general paediatric, or intensive care units (ICUs) in Australia and Aotearoa New Zealand (AoNZ) following the first publication in 2016.Method: The Paediatric Research in Emergency Departments International Collaborative (PREDICT) network guideline working group appraised, summarised, and updated evidence from 1 January 2000 to 24 January 2024 addressing 41 questions (30 from the 2016 guideline and 11 new questions for 2025). Recommendations were developed using GRADE methodology and revised after a period of external consultation.Results: The literature search identified 26 467 citations with 431 included in 41 recommendations providing 11 new and 7 key updates. The key changes included: (i) refinement of the clinical features of bronchiolitis, (ii) addition of new risk factors for severity of illness, (iii) advice on the role of biomarkers for unexpected deterioration or admission to ICU, (iv) guidance on glucocorticoids in SARS‐CoV‐2 co‐infection, (v) guidance on combined glucocorticoids/inhaled epinephrine in severe bronchiolitis requiring ICU level care, (vi) refinement of oxygen saturation targets, (vii) guidance on humidified high flow therapy and continuous positive airway pressure, (viii) recommendation on use of RSV prevention therapies/immunisations for babies and mothers.Conclusion: The updated Australasian Bronchiolitis Guideline provides clinicians across Australasian settings with the latest evidence‐based guidance on the management of the commonest condition in infancy requiring hospital admission.
- Open Access
- 17 July 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (8) , 1169-1181
Methodology of the Updated and Expanded Australasian Bronchiolitis Guideline
Background: Bronchiolitis is the most common reason for hospital admission in infants in Australia and Aotearoa New Zealand (AoNZ), with care historically affected by practice variation, including use of ineffective therapies. The Paediatric Research in Emergency Departments International Collaborative (PREDICT) developed the first Australasian (Australia, AoNZ) bronchiolitis guideline in 2016, providing evidence‐based guidance on the management of infants (< 12 months of age), presenting or admitted to hospital with bronchiolitis. In 2022, PREDICT initiated a guideline update to include new evidence and expand the scope to include intensive care (up to intubation), management of SARS‐CoV‐2 co‐infection, and respiratory syncytial virus prevention.Aim: This article outlines the methodology used in the guideline update, following AGREE and CheckUp reporting standards.Methods: A Guideline Advisory Group and Guideline Development Committee, consisting of 29 clinical and methodological experts from Australasia, developed the guideline with consumer input. Forty‐one scoping questions on 25 topics were investigated. Systematic searches were performed by a subject librarian across five electronic databases (last search 24/01/24). Screening of 13,932 new articles occurred independently, in duplicate in two stages. The results of 431 articles were synthesized narratively and quantitatively where appropriate, per topic. Risk of bias was evaluated using appropriate tools. GRADE methodology was used to assess evidence quality and develop the recommendations, which were finalised through consensus voting across three guideline development meetings.Results: The update produced 41 recommendations (33 evidence‐based, 8 consensus‐based; including 11 new and 7 with key revisions), covering bronchiolitis investigations, management and RSV prevention. Interest‐holder groups consulted on the recommendations.Conclusion: The Australasian Bronchiolitis Guideline was updated and expanded according to AGREE and CheckUp reporting standards.
- 17 July 2025
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (8) , 1169-1181
Open AccessMethodology of the Updated and Expanded Australasian Bronchiolitis Guideline
Background: Bronchiolitis is the most common reason for hospital admission in infants in Australia and Aotearoa New Zealand (AoNZ), with care historically affected by practice variation, including use of ineffective therapies. The Paediatric Research in Emergency Departments International Collaborative (PREDICT) developed the first Australasian (Australia, AoNZ) bronchiolitis guideline in 2016, providing evidence‐based guidance on the management of infants (< 12 months of age), presenting or admitted to hospital with bronchiolitis. In 2022, PREDICT initiated a guideline update to include new evidence and expand the scope to include intensive care (up to intubation), management of SARS‐CoV‐2 co‐infection, and respiratory syncytial virus prevention.Aim: This article outlines the methodology used in the guideline update, following AGREE and CheckUp reporting standards.Methods: A Guideline Advisory Group and Guideline Development Committee, consisting of 29 clinical and methodological experts from Australasia, developed the guideline with consumer input. Forty‐one scoping questions on 25 topics were investigated. Systematic searches were performed by a subject librarian across five electronic databases (last search 24/01/24). Screening of 13,932 new articles occurred independently, in duplicate in two stages. The results of 431 articles were synthesized narratively and quantitatively where appropriate, per topic. Risk of bias was evaluated using appropriate tools. GRADE methodology was used to assess evidence quality and develop the recommendations, which were finalised through consensus voting across three guideline development meetings.Results: The update produced 41 recommendations (33 evidence‐based, 8 consensus‐based; including 11 new and 7 with key revisions), covering bronchiolitis investigations, management and RSV prevention. Interest‐holder groups consulted on the recommendations.Conclusion: The Australasian Bronchiolitis Guideline was updated and expanded according to AGREE and CheckUp reporting standards.
- Open Access
- 27 June 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67941
Validation and Comparison of Pediatric Appendicitis Scores and Management Strategies (Project SPASMS): Protocol for a Prospective Multicenter Observational Study
Background: Abdominal pain is a common reason for children to attend the Emergency Department (ED) with acute appendicitis being the most common surgical cause. Various clinical prediction scores (CPSs) have been developed to assist in determining the risk of appendicitis; however, CPSs have been inadequately validated in children and haphazardly adopted in Australia and New Zealand (ANZ) EDs. Objective: This study aims to compare and validate various CPSs for diagnosing pediatric appendicitis in children presenting to ANZ EDs. Methods: This prospective multicenter observational study across 10 ANZ EDs is recruiting children 5-17 years presenting to participating EDs with acute right-sided or generalized abdominal pain lasting ≤7 days and clinician suspicion of appendicitis. CPSs will be calculated by the study team from clinician-recorded data and clinician gestalt recorded on a visual analog scale. Accuracy of CPSs will be assessed by the area under the receiver operating characteristic curve and proportions correctly identified as either low-risk or high-risk based on the CPSs published cutoffs. The final diagnosis of appendicitis will be confirmed on histopathology, and the absence of appendicitis confirmed by telephone, email, or a combination of both to follow up for those discharged directly from ED. Results: This study received funding in July 2023 and started enrolment in August 2023. As of October 2024, we have enrolled and completed follow-up on 1227 participants with an expected end date in mid-2025. Conclusions: This study aims to determine the best-performing CPS for diagnosing pediatric appendicitis in ANZ EDs. Implementation of this CPS in ANZ EDs has the potential to reduce health care costs, rationalize the use of health care resources, and improve the management and outcomes of childhood appendicitis. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12622001293752; https://tinyurl.com/242wwenx International Registered Report Identifier (IRRID): DERR1-10.2196/67941
- 27 June 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e67941
Open AccessValidation and Comparison of Pediatric Appendicitis Scores and Management Strategies (Project SPASMS): Protocol for a Prospective Multicenter Observational Study
Background: Abdominal pain is a common reason for children to attend the Emergency Department (ED) with acute appendicitis being the most common surgical cause. Various clinical prediction scores (CPSs) have been developed to assist in determining the risk of appendicitis; however, CPSs have been inadequately validated in children and haphazardly adopted in Australia and New Zealand (ANZ) EDs. Objective: This study aims to compare and validate various CPSs for diagnosing pediatric appendicitis in children presenting to ANZ EDs. Methods: This prospective multicenter observational study across 10 ANZ EDs is recruiting children 5-17 years presenting to participating EDs with acute right-sided or generalized abdominal pain lasting ≤7 days and clinician suspicion of appendicitis. CPSs will be calculated by the study team from clinician-recorded data and clinician gestalt recorded on a visual analog scale. Accuracy of CPSs will be assessed by the area under the receiver operating characteristic curve and proportions correctly identified as either low-risk or high-risk based on the CPSs published cutoffs. The final diagnosis of appendicitis will be confirmed on histopathology, and the absence of appendicitis confirmed by telephone, email, or a combination of both to follow up for those discharged directly from ED. Results: This study received funding in July 2023 and started enrolment in August 2023. As of October 2024, we have enrolled and completed follow-up on 1227 participants with an expected end date in mid-2025. Conclusions: This study aims to determine the best-performing CPS for diagnosing pediatric appendicitis in ANZ EDs. Implementation of this CPS in ANZ EDs has the potential to reduce health care costs, rationalize the use of health care resources, and improve the management and outcomes of childhood appendicitis. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12622001293752; https://tinyurl.com/242wwenx International Registered Report Identifier (IRRID): DERR1-10.2196/67941
- Open Access
- 25 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Validation and Comparison of Pediatric Appendicitis Scores and Management Strategies (Project SPASMS): Protocol for a Prospective Multicenter Observational Study (Preprint)
BACKGROUND Abdominal pain is a common reason for children to attend the Emergency Department (ED) with acute appendicitis being the most common surgical cause. Various clinical prediction scores (CPSs) have been developed to assist in determining the risk of appendicitis; however, CPSs have been inadequately validated in children and haphazardly adopted in Australia and New Zealand (ANZ) EDs. OBJECTIVE This study aims to compare and validate various CPSs for diagnosing pediatric appendicitis in children presenting to ANZ EDs. METHODS This prospective multicenter observational study across 10 ANZ EDs is recruiting children 5-17 years presenting to participating EDs with acute right-sided or generalized abdominal pain lasting ≤7 days and clinician suspicion of appendicitis. CPSs will be calculated by the study team from clinician-recorded data and clinician gestalt recorded on a visual analog scale. Accuracy of CPSs will be assessed by the area under the receiver operating characteristic curve and proportions correctly identified as either low-risk or high-risk based on the CPSs published cutoffs. The final diagnosis of appendicitis will be confirmed on histopathology, and the absence of appendicitis confirmed by telephone, email, or a combination of both to follow up for those discharged directly from ED. RESULTS This study received funding in July 2023 and started enrolment in August 2023. As of October 2024, we have enrolled and completed follow-up on 1227 participants with an expected end date in mid-2025. CONCLUSIONS This study aims to determine the best-performing CPS for diagnosing pediatric appendicitis in ANZ EDs. Implementation of this CPS in ANZ EDs has the potential to reduce health care costs, rationalize the use of health care resources, and improve the management and outcomes of childhood appendicitis. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN12622001293752; https://tinyurl.com/242wwenx INTERNATIONAL REGISTERED REPORT DERR1-10.2196/67941
- 25 October 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessValidation and Comparison of Pediatric Appendicitis Scores and Management Strategies (Project SPASMS): Protocol for a Prospective Multicenter Observational Study (Preprint)
BACKGROUND Abdominal pain is a common reason for children to attend the Emergency Department (ED) with acute appendicitis being the most common surgical cause. Various clinical prediction scores (CPSs) have been developed to assist in determining the risk of appendicitis; however, CPSs have been inadequately validated in children and haphazardly adopted in Australia and New Zealand (ANZ) EDs. OBJECTIVE This study aims to compare and validate various CPSs for diagnosing pediatric appendicitis in children presenting to ANZ EDs. METHODS This prospective multicenter observational study across 10 ANZ EDs is recruiting children 5-17 years presenting to participating EDs with acute right-sided or generalized abdominal pain lasting ≤7 days and clinician suspicion of appendicitis. CPSs will be calculated by the study team from clinician-recorded data and clinician gestalt recorded on a visual analog scale. Accuracy of CPSs will be assessed by the area under the receiver operating characteristic curve and proportions correctly identified as either low-risk or high-risk based on the CPSs published cutoffs. The final diagnosis of appendicitis will be confirmed on histopathology, and the absence of appendicitis confirmed by telephone, email, or a combination of both to follow up for those discharged directly from ED. RESULTS This study received funding in July 2023 and started enrolment in August 2023. As of October 2024, we have enrolled and completed follow-up on 1227 participants with an expected end date in mid-2025. CONCLUSIONS This study aims to determine the best-performing CPS for diagnosing pediatric appendicitis in ANZ EDs. Implementation of this CPS in ANZ EDs has the potential to reduce health care costs, rationalize the use of health care resources, and improve the management and outcomes of childhood appendicitis. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN12622001293752; https://tinyurl.com/242wwenx INTERNATIONAL REGISTERED REPORT DERR1-10.2196/67941
- 19 March 2019
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 37 (12) , 593-598
Pediatric Abdominal Pain in Children Presenting to the Emergency Department
Background: Undifferentiated abdominal pain is a common pediatric presentation to the emergency department (ED). Objectives: The objective of this study was to describe the prevalence of clinically significant abdominal pathology (CSAP) including appendicitis, patterns of imaging and pathology tests, and management and outcomes of children with abdominal pain in ED. Methods: A prospective multicenter observational cohort pilot study of children under the age of 16 years presenting to 4 Australian EDs with abdominal pain was performed for a 1-month period at each site. The primary outcome was to describe the prevalence of CSAP and appendicitis. Age, sex, length of stay, surgery or interventional procedure, investigations, and analgesia use were recorded. Results: There were 555 presentations with abdominal pain during the study period with a median age of 9 years (interquartile range, 6–12 years). Eighty-two patients (14.8%; 95% confidence interval, 11.8–17.7) had CSAP, of which 41 (7.4%, 5.2–9.6) had appendicitis. Three hundred forty-eight (62.7%, 58.7–66.7) were discharged directly from ED, and 207 (37.3%, 33.2–41.3) were admitted. Two hundred fifty-five (45.9%, 41.8–50.1) had pathology tests, and 173 (31.2%, 27.3–35.1) had imaging tests in ED. Of those contacted for telephone follow-up, 100 (50.5%, 43.5–57.5) of 198 reported ongoing pain after discharge, and 13.1% (8.4–17.8) had missed over a week of school due to abdominal pain. Conclusions: The prevalence of CSAP and appendicitis in our study was 14.8% (11.8–17.7) and 7.4% (5.2–9.6), respectively. Fewer than half of patients received blood tests, and a third received imaging during their ED attendance. The presentation of abdominal pain conveys a significant health burden on families with time off school and ongoing symptoms of pain.
- 19 March 2019
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 37 (12) , 593-598
Pediatric Abdominal Pain in Children Presenting to the Emergency Department
Background: Undifferentiated abdominal pain is a common pediatric presentation to the emergency department (ED). Objectives: The objective of this study was to describe the prevalence of clinically significant abdominal pathology (CSAP) including appendicitis, patterns of imaging and pathology tests, and management and outcomes of children with abdominal pain in ED. Methods: A prospective multicenter observational cohort pilot study of children under the age of 16 years presenting to 4 Australian EDs with abdominal pain was performed for a 1-month period at each site. The primary outcome was to describe the prevalence of CSAP and appendicitis. Age, sex, length of stay, surgery or interventional procedure, investigations, and analgesia use were recorded. Results: There were 555 presentations with abdominal pain during the study period with a median age of 9 years (interquartile range, 6–12 years). Eighty-two patients (14.8%; 95% confidence interval, 11.8–17.7) had CSAP, of which 41 (7.4%, 5.2–9.6) had appendicitis. Three hundred forty-eight (62.7%, 58.7–66.7) were discharged directly from ED, and 207 (37.3%, 33.2–41.3) were admitted. Two hundred fifty-five (45.9%, 41.8–50.1) had pathology tests, and 173 (31.2%, 27.3–35.1) had imaging tests in ED. Of those contacted for telephone follow-up, 100 (50.5%, 43.5–57.5) of 198 reported ongoing pain after discharge, and 13.1% (8.4–17.8) had missed over a week of school due to abdominal pain. Conclusions: The prevalence of CSAP and appendicitis in our study was 14.8% (11.8–17.7) and 7.4% (5.2–9.6), respectively. Fewer than half of patients received blood tests, and a third received imaging during their ED attendance. The presentation of abdominal pain conveys a significant health burden on families with time off school and ongoing symptoms of pain.